Dietary salt restriction increases vascular insulin resistance

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 4, 1996, Pages 444-451

  Feldman, Ross D ^a   Logan, Alexander G ^b   Schmidt, Nancy D ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN; SODIUM CHLORIDE;

ADULT; ARTERIAL PRESSURE; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET; DOUBLE BLIND PROCEDURE; GLUCOSE METABOLISM; HUMAN; HYPERTENSION; INSULIN RESISTANCE; LIPID METABOLISM; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM RESTRICTION; VASCULAR RESISTANCE; VASODILATATION;

ADULT; BLOOD PRESSURE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; ELECTROLYTES; HUMANS; HYPERTENSION; INSULIN; MALE; NOREPINEPHRINE; SODIUM CHLORIDE, DIETARY; VASODILATION; VEINS;

EID: 0029856372     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90201-5     Document Type: Article

References (39)

1. Intersalt co-operative research group. Intersalt: an international study of electrolyte excretion and blood pressure: results for 24 hour urinary sodium and potassium excretion. Br Med J 1988;297:319-28.
2. Stamler R, Stamler J, Grimm R, Gosch FC, Elmer P, Dyer A, et al. Nutritional therapy for high blood pressure: final report of a four-year randomized controlled trial - the Hypertension Control Program. JAMA 1987;257:1484-91.
3. The Treatment of Mild Hypertension Research Group. The treatment of mild hypertension study: a randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. Arch Intern Med 1991;151:1413-23.
4. Midgley JP, Matthew AG, Greenwood CM, Logan AG. Effect of reduced dietary sodium on blood pressure: a meta-analysis of randomized controlled trials. JAMA 1996;275:1590-7.
5. Alderman MH, Madhavan S, Cohen H, Sealey JE, Laragh JH. Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension 1995;25:1144-52.
6. Anderson EA, Sinkey CA, Lawton WJ, Mark AL. Elevated sympathetic nerve activity in borderline hypertensive humans. Evidence from direct intraneural recordings. Hypertension 1989;14:177-83.
7. Esler M, Jennings G, Korner P, Willett I, Dudley F, Hasking G, et al. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 1988;11:3-20.
8. Ruppert M, Diehl J, Kolloch R, Overlack A, Kraft K, Gobel B, et al. Short-term dietary sodium restriction increases serum lipids and insulin in salt sensitive and salt resistance normotensive adults. Klin Wochenschr 1992;69(suppl 35):51-7.
9. Weder AB, Egan BM. Potential deleterious impact of dietary salt restriction on cardiovascular risk factors. Klin Wochenschr 1991;69(suppl 25):45-50.
10. Egan BM, Weder AB, Petrin J, Hoffman RG. Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status. Am J Hypertens 1991;4:416-21.
11. Egan BM, Stepniakowski K. Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension. Am J Cardiol 1993;72:53-7.
12. Egan BM, Stepniakowski K, Nazzaro P. Insulin levels are similar in obese salt sensitive and salt-resistant hypertensive subjects. Hypertension 1994;23:I1-I7.
13. Anderson EA, Mark AL. The vasodilator action of insulin: implications for the insulin hypothesis of hypertension. Hypertension 1993;21:136-41.
14. Ferrannini E, Buzzigoli RD, Giorico MA, Bonadonna R, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
15. Natali A, Santoro D, Palombo C, Cerri M, Ghione S, Ferrannini E. Impaired insulin action on skeletal muscle metabolism in essential hypertension. Hypertension 1991;17:170-8.
16. Capaldo B, Lembo G, Napoli R, Rendina V, Albani G, Sacca L, et al. Skeletal muscle is a primary site of insulin resistance in essential hypertension. Metabolism 1991;40:1320-2.
17. Feldman RD, Bierbrier GS. Insulin-mediated vasodilation: impairment with increased blood pressure and body mass. Lancet 1993;342:707-9.
18. Creager MA, Laing CS, Coffman JD. Beta adrenergic-mediated vasodilator response to insulin in the human forearm. J Pharmacol Exp Ther 1985; 235:709-14.
19. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
20. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest 1990;85:1844-53.
21. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow: a possible link between insulin resistance and blood pressure. Hypertension 1993;21:129-35.
22. Feldman RD, Hramiak IM, Finegood DT, Behme MT. Parallel regulation of the local vascular and systemic metabolic effects of insulin. J Clin Endocrinol Metab 1995;80:1556-9.
23. Feldman RD. Defective venous β-adrenergic response in borderline hypertensive subjects is corrected by a low sodium diet. J Clin Invest 1990;85: 647-52.
24. Feldman RD. A low-sodium diet corrects the defect in β-adrenergic response in elder subjects. Circulation 1992;85:612-8.
25. Naslund T, Silberstein DJ, Merrell WJ, Nadeau JH, Wood AJJ. Low sodium intake corrects abnormality in β-receptor mediated arterial vasodilation in patients with hypertension: correlation with β-receptor function in vitro. Clin Pharmacol Ther 1990;48:87-95.
26. Takeshita A, Mark AL. Decreased vasodilator capacity of forearm resistance vessels in borderline hypertension. Hypertension 1990;2:610-6.
27. Schulte KL, Braun J, Meyer-Sabellek W, Wegscheider K, Gotzen R, Distler A. Functional versus structural changes of forearm vascular resistance in hypertension. Hypertension 1988;11:320-5.
28. Webb RC, Bohr DF. Recent advances in the pathogenesis of hypertension: consideration of structural, functional, and metabolic vascular abnormalities resulting in elevated arterial resistance. Am Heart J 1981;102:251-64.
29. Iwaoka T, Umeda T, Ohno M, Inoue J, Naomi S, Sato T, et al. The effect of low and high NaCl diets on oral glucose tolerance. Klin Wochenschr 1988;66:724-8.
30. Goodfriend TL, Ball DL, Weinberger MH, Moore TJ, Weder AB, Egan BM. Salt loads raise plasma fatty acids and lower insulin. Hypertension 1991;17:958-64.
31. Sharma AM, Schorr U, Distler A. Insulin resistance in young salt-sensitive normotensive subjects. Hypertension 1993;21:273-9.
32. Donovan DS, Solomon CG, Seely EW, Williams GH, Simonson D. Effect of sodium intake on insulin sensitivity. Am J Physiol 1993;264 (Endocrinol Metab 27):E730-4.
33. Wong FS, Miller JA, Blendis LM, Logan AG. Effect of insulin on the venoconstrictive response to norepinephrine in normal human subjects: the influence of sodium status. Am J Hypertens 1994;7: 1097-104.
34. Steinberg HO, Brechtel G, Johnson A, Fineberg N, Baron A. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent: a novel action of insulin to increase nitric oxide release. J Clin Invest 1994;94: 1172-9.
35. van Zwieten PA, Safar M, Laurent S, Pfaffendorf M, Hendriks MGC, Bruning TA. New insights into the role of endothelial dysfunction in hypertension. J Hypertens 1995;13:713-6.
36. Julius S, Jamerson K. Sympathetics insulin resistance and coronary risk in hypertension: the "chicken-and-egg" question. J Hypertens 1994;12:495-502.
37. Parfrey PS, Vandenburg MJ, Wright P, Holly JMP, Goodwin FJ, Evans SJW, et al. Blood pressure and hormonal changes following alteration in dietary sodium and potassium in mild essential hypertension. Lancet 1981;319:59-63.
38. MacGregor GA, Markandu ND, Sagnella GS, Singer DRJ, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet 1989;334:1244-7.
39. Eichler HG, Ford GA, Blaschke TF, Swislocki A, Hoffman BB. Responsiveness of superficial hand veins to phenylephrine in essential hypertension. J Clin Invest 1989;83:108-12.